Östergötland Sörmland Jönköping Jämtland Kronoberg Skåne Västerbotten Västmanland Gävleborg Örebro Värmland SWEDEN Kalmar Blekinge Halland Uppsala Västernorrland Dalarna Västra Götaland Stockholm Gotland Norrbotten
0–4 months 94.8 94.9 93.2 90.9 92.0 92.4 92.4 94.0 91.6 92.7 92.7 91.4 92.0 92.6 93.4 89.8 90.7 90.0 90.4 88.4 85.5 89.2
88.9 87.8 87.4 86.7 86.5 86.1 85.8 85.8 85.3 84.5 84.0 83.9 83.7 83.6 83.5 83.2 82.9 82.8 82.7 79.9 79.0 78.7 0
20
40
60
80
100
Percent
2007–2008
Figure 94
Lipid lowering drug therapy 12–18 months after myocardial infarction, in patients age 40–79, 2009–2010. Age-standardised. Source: National Patient Register and Prescribed Drug Register, National Board of Health and Welfare
90
Percent
80
Total
70
Women Men
2005-2006
Figure 94 Sweden
2007-2008
2009-2010
Lipid lowering drug therapy 12–18 months after myocardial infarction, in patients age 40–79. Age-standardised. Source: National Patient Register and Prescribed Drug Register, National Board of Health and Welfare
The indicator was once part of the RIKS-HIA Quality Index for hospitals, targeting treatment in 90–95 per cent of patients. Given that no county reached 90 per cent 12–18 months after hospitalisation for myocardial infarction in 2009–2010, patients appear to have been undertreated.
198
QUALITY AND EFFICIENCY IN SWEDISH HEALTH CARE 2012